Sort by
Refine Your Search
-
for a highly motivated and team-science minded Postdoctoral Fellow, to study the molecular mechanisms involved in regulating functional beta cell mass, skeletal muscle insulin action, whole body glucose
-
of the Division of Epigenetics and Transcriptional Engineering at City of Hope Cancer Center. His lab investigates epigenetic mechanisms of drug resistance and identifies therapeutic targets in various
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
Fellowship within the laboratory of Dr Ed Boas, at the Beckman Research Institute of City of Hope. For more information on his research please visit here . We are looking for a biomedical engineer, materials
-
, shaping the future of medicine through cutting-edge research. Join Dr. Marcel van den Brink’s multidisciplinary team to explore innovative ways to decipher the molecular mechanisms of thymic regeneration
-
, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation Oncology and
-
, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation Oncology and
-
have been focused on exploring the molecular mechanisms of leukemogenesis and evolution, discovery of novel therapeutic targets, and development of novel therapeutic strategies, including novel
-
, shaping the future of medicine through cutting-edge research. An exciting opportunity is available in the laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation
-
on drug development and discovery of basic mechanisms and novel therapeutic targets of leukemogenesis, and genetic and epigenetic prognostic biomarkers in acute myeloid leukemia (AML). We conduct research